CDT Equity Inc. (CDT)
D
Pipeline Grade
Financial Position (from SEC Filings)
$1.5M
Cash & Equivalents
$15.6M
Quarterly Burn Rate
$2M
Market Cap
Estimated from most recent SEC quarterly filing. View SEC filings
Drug Pipeline (0 Assets)
No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.
Upcoming Catalysts
| Date | Event | Drug |
|---|---|---|
| 2026-10-20 | Phase3 Readout | — |
Active Clinical Trials (1)
| NCT # | Title | Phase | Status | Enrollment |
|---|---|---|---|---|
| NCT05531565 | A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Act... | PHASE3 | Active Not Recruiting | 450 |
Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.